
Long COVID May Set Off New Allergies Through Immune Dysregulation
New evidence suggests long COVID is associated with persistent immune dysregulation that may drive new allergic conditions. Studies link SARS-CoV-2 infection to higher risks of asthma, allergic rhinitis, and chronic rhinosinusitis, with vaccination offering protection. Some researchers also point to mast cell activation syndrome as part of long COVID's allergic manifestations. Clinicians report anecdotal and clinic-based increases in allergies post-COVID and call for early screening, biomarker research, and prospective trials to prevent or modify these outcomes.

